Neurodegenerative diseases are incurable and debilitating conditions that result in the progressive degeneration of nerve cells, which affect the cognitive activity. Currently, as a result of multiple studies linking Alzheimer's disease (AD) to oxidative damage, the uses of natural antioxidant to prevent, delay, or enhance the pathological changes underlying the progression of AD has received considerable attention. Therefore, this study was aimed at examining the effect of ethanolic extracts of Phyllanthus emblica (EEPE) ripe (EEPEr) and EEPE unripe (EEPEu) fruits on cognitive functions, brain antioxidant enzymes, and acetylcholinesterase (AChE) activity in rat. The effects of EEPEr and EEPEu fruits (i.e., 100 and 200 mg/kg b.w.) were examined in Swiss albino male rats for 12 days and its effect on cognitive functions, brain antioxidant enzymes, and AChE activity determined. Learning and memory enhancing activity of EEPE fruit was examined by using passive avoidance test and rewarded alternation test. Antioxidant potentiality was evaluated by measuring the activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase, reduced glutathione (GSH), glutathione-S-transferase, and the contents of thiobarbituric acid reactive substances (TBARS) in entire brain tissue homogenates. AChE activity was determined using colorimetric method. Administration of the highest dose (i.e., 200 mg/kg b.w.) of EEPEr fruit significantly (p < 0.01) and both lowest and highest doses (i.e., 100 and 200 mg/kg b.w.) of EEPEu fruit markedly (p < 0.05, p < 0.001) increased step-through latency in rats on 6th, 11th, and 12th day with respect to the control group. For aforementioned doses, the percentage of memory retention (MR) was considerably (p < 0.05, p < 0.01) increased in rats on 10th, 11th, and 12th days with respect to the control group. The extract, particularly highest dose (i.e., 200 mg/kg b.w.) of EEPEr fruit markedly (p < 0.05) and lowest and highest doses (i.e., 100 and 200 mg/kg b.w.) of EEPEu fruit significantly (p < 0.01) increased the correct responses in rats on 6th, and 12th day related to the control group. In case of this test, the percentage of MR was significantly (p < 0.05, p < 0.01) increased in rats treated with aforementioned doses on 12th day with respect to the control group. The highest dose (i.e., 200 mg/kg b.w.) of EEPEr fruit suggestively (p < 0.05) and both lowest and highest doses (i.e., 100 and 200 mg/kg b.w.) of EEPEu fruit suggestively (p < 0.05, p < 0.01, p < 0.001) increased the levels of SOD, CAT, GSH, GSH-Px and expressively (p < 0.01) decreased the TBARS level compared to the control group. Treatment with the highest dose (i.e., 200 mg/kg b.w.) of EEPEr fruit significantly (p < 0.05) and both lowest and highest doses (i.e., 100 and 200 mg/kg b.w.) of EEPEu fruit markedly (p < 0.01, p < 0.001) decreased the level of AChE activity compared to that of the control group. The present study shows that EEPE fruit possesses an excellent source for natural cognitive enhancer which could be developed in the treatment of AD and other neurodegenerative diseases.

Keywords:
Phyllanthus emblica, Cognitive performance, Brain antioxidant markers, Acetylcholinesterase, Alzheimer’s disease
1.
Uddin MS, Mamun AA, Iqbal MA, Islam A, Hossain MF, Khanum S, Rashid M: Analyzing nootropic effect of Phyllanthus reticulatus Poir. on cognitive functions, brain antioxidant enzymes and acetylcholinesterase activity against aluminium-induced Alzheimer's model in rats: applicable for controlling the risk factors of Alzheimer's disease. Adv Alzheimer Dis 2016;5:87-102.
2.
Solomon Arunodhayan Sam D, Henri C, Sushmitha, et al: Neuron the memory unit of the brain. J Compu Enginee 2015;17:48-61.
3.
Selnes OA, Vinters HV: Vascular cognitive impairment. Nat Clin Pract Neuro 2006;2:538-547.
4.
Chauhan V, Chaudhary A: Alzheimer's disease: a literature review. Eur J Pharma Pand Med Res 2015;2:201-207.
5.
Querfurth HW, LaFerla FM: Alzheimer's disease. N Engl J Med 2010;362:329-344.
6.
Wimo A, Winblad B, Aguero-Torres H, et al: The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003;17:63-67.
7.
Mamun AA, Uddin MS, Wahid F, Iqbal MA, Rahman MM: Neurodefensive effect of Olea europaea L. in alloxan-induced cognitive dysfunction and brain tissue oxidative stress in mice: incredible natural nootropic. J Neuro Neurosci 2016;7:1.
8.
Serrano-Pozo A, Frosch MP, Masliah E, et al: Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011;1:a006189.
9.
Wray S, Noble W: Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity. J Neurosci 2009;29:9665-9667.
10.
Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
11.
Kuhla B, Haase C, Flach K, et al: Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem 2007;282:6984-6991.
12.
Selley M, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging 2002;23:383-388.
13.
Bradley MA, Markesbery WR, Lovell MA: Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 2010;48:1570-1576.
14.
Sultana R, Butterfield DA: Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 2010;19:341-353.
15.
Uddin MS, Mamun AA, Khanum S, Begum Y, Alam MS: Analysis of in vitro antioxidant activity of Caryota urens L. leaves: a traditional natural remedy. J Coast Life Med 2016;4:483-489.
16.
Zhao Y, Zhao B: Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev 2013;2013:316523.
17.
Agostinho P, Cunha RA, Oliveira C: Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 2010;16:2766-2778.
18.
Asaduzzaman M, Uddin MJ, Kader MA, et al: In vitro acetylcholinesterase inhibitory activity and the antioxidant properties of Aegle marmelos leaf extract: implications for the treatment of Alzheimer's disease. Psychogeriatrics 2014;14:1-10.
19.
Mwitari PG, Ayeka PA, Ondicho J, et al: Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus Africana and Plectrunthus barbatus. PLoS One 2013;8:e65619.
20.
Kayne SB: Traditional Medicine, ed 1. London, Pharmaceutical Press, 2010.
21.
Duraipandiyan V, Ayyanar M, Ignacimuthu S: Antimicrobial activity of some ethnomedicinal plants used by Paliyar tribe from Tamil Nadu, India. BMC Complement Altern Med 2006;6:35.
22.
Bhattacharjee A, Shashidhara SC, Saha S: Nootropic activity of Crataeva nurvala Buch-Ham against scopolamine induced cognitive impairment. EXCLI J 2015;14:335-345.
23.
Oken BS, Storzbach DM, Kaye JA: The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998;55:1409-14015.
24.
Goswami S, Saoji A, Kumar N, et al: Effect of Bacopa monnierion cognitive functions in Alzheimer's disease patients. Int J Colla Res Int Medi Pub Heal 2011;3:285-289.
25.
Skolnick AA: Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy. JAMA 1997;277:776.
26.
Zhu X, Wang J, Ou Y, et al: Polyphenol extract of Phyllanthus emblica (PEEP) induces inhibition of cell proliferation and triggers apoptosis in cervical cancer cells. Eur J Med Res 2013;18:46.
27.
Hossen Moazzem SM, Sarkar R, Mahmud S, et al: Medicinal potential of Phyllanthus emblica (Linn.) fruits extracts: biological and pharmacological activities. Bri J Pharma Re 2014;4:1486-1499.
28.
Krishnaveni M, Mirunalini S: Amla - the role of ayurvedic therapeutic herb in cancer. Asi J Pharma Cli Res 2011;4:13.
29.
Zhang YJ, Tanaka T, Iwamoto Y, et al: Phyllaemblic acid, a novel highly oxygenated norbisabolane from the roots of Phyllanthus emblica. Tetrahedron Lett 2000;41:1781-1784.
30.
Perianayagam JB, Sharma SK, Joseph A, et al: Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol 2004;95:83-85.
31.
Krishnaveni M, Mirunalini S: Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol 2010;21:93-105.
32.
Dasaroju S, Gottumukkala KM: Current trends in the research of Emblica officinalis (Amla): a pharmacological perspective. Int J Pharm Sci Rev Res 2014;24:150.
33.
Ihantola-Vormisto A, Summanen J, Kankaanranta H, et al: Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 1997;63:518-524.
34.
Dhale DA, Mogle UP: Phytochemical screening and antibacterial activity of Phyllanthus emblica (L.). Sci Res Reporte 2011;1:138-142.
35.
Raghu HS, Ravindra P: Antimicrobial activity and phytochemical study of Phyllanthus emblica Linn. Int J Pharma Stud Res 2010;1:30-33.
36.
Iamsaard S, Arun S, Burawat J, et al: Phenolic contents and antioxidant capacities of Thai-Makham Pom (Phyllanthus emblica L.) aqueous extracts. J Zhejiang Univ Sci B 2014;15:405-408.
37.
Ashwlayan VD, Singh R: Reversal effect of Phyllanthus emblica (euphorbiaceae) rasayana on memory deficits in mice. Int J App Pharmace 2011;3:10-15.
38.
National Research Council: Guide for the Care and Use of Laboratory Animals, ed 8. Washington, National Academies Press, 2011.
39.
Weon JB, Lee J, Eom MR, et al: The effects of Loranthus parasiticus on scopolamine-induced memory impairment in mice. Evid Based Complement Alternat Med 2014;2014:860180.
40.
Tasanarong A, Kongkham S, Itharat A: Antioxidant effect of Phyllanthus emblica extract prevents contrast-induced acute kidney injury. BMC Complement Altern Med 2014;14:138.
41.
Organisation for Economic Cooperation and Development: OECD Guidelines for the Testing of Chemicals: Acute Oral Toxicity - Acute Toxic Class Method. Paris, OECD, 2002.
42.
Akar F, Mutlu O, Komsuoglu Celikyurt I, et al: Zaprinast and Rolipram enhances spatial and emotional memory in the elevated plus maze and passive avoidance tests and diminishes exploratory activity in naive mice. Med Sci Monit Basic Res 2014;20:105-111.
43.
van der Staay FJ, Schuurman T, van Reenen CG, et al: Emotional reactivity and cognitive performance in aversively motivated tasks: a comparison between four rat strains. Behav Brain Funct 2009;5:50.
44.
Wang J, Wang X, Lv B, et al: Effects of Fructus akebiae on learning and memory impairment in a scopolamine-induced animal model of dementia. Exp Ther Med 2014;8:671-675.
45.
Morris R: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47-60.
46.
Saadipour K, Sarkaki A, Alaei H, et al: Forced exercise improves passive avoidance memory in morphine-exposed rats. Pak J Biol Sci 2009;12:1206-1211.
47.
Benchenane K, Castel H, Boulouard M, et al: Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. J Cell Sci 2007;120(pt 4):578-585.
48.
Sossin WS, Lacaille JC, Castellucci VF, et al: Progress in Brain Research; Essence of Memory, ed 1. Netherland, Elsevir, 2008.
49.
Rao MK, Rao MS, Rao GS: Treatment with Centalla asiatica (Linn) fresh leaf extract enhances learning ability and memory retention power in rats. Neurosciences (Riyadh) 2007;12:236-241.
50.
Deacon RM, Rawlins JN: T-maze alternation in the rodent. Nat Protoc 2006;1:7-12.
51.
Kameyama T, Nabeshima T, Kozawa T: Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models. J Pharmacol Methods 1986;16:39-52.
52.
Kakkar P, Das B, Viswanathan PN: A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130-132.
53.
Chance B, Maehly AC: Assay of catalase and peroxidases. Meth Enzymo 1955;11:764-775.
54.
Mohandas J, Marshall JJ, Duggin GG, et al: Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy. Biochem Pharmacol 1984;33:1801-1807.
55.
Bhaskar M, Chintamaneni M: Investigating the role of Eclipta alba on brain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats. Int J Pharm Phytopharmacol Res 2014;3:390-394.
56.
Jollow DJ, Mitchell JR, Zampaglione N, et al: Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974;11:151-169.
57.
Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
58.
Iqbal M, Sharma MD, Rezazadeh HR, et al: Glutathione metabolizing enzymes and oxidative stress in ferric nitrilotriacetate mediated hepatic injury. Redox Report 1996;2:385-391.
59.
Ellman GL, Courtney KD, Andres V Jr, et al: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
60.
Ncube NS, Afolayan AJ, Okoh AI: Assessment techniques of antimicrobial properties of natural compounds of plant origin: current methods and future trends. Afr J Biotechnol 2008;7:1797-1806.
61.
Kumar GP, Khanum F: Neuroprotective potential of phytochemicals. Pharmacogn Rev 2012;6:81-90.
62.
Gong X, Sucher NJ: Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol Sci 1999;20:191-196.
63.
Valcheva-Kuzmanova SV, Eftimov MT, Tashev RE, et al: Memory effects of Aronia melanocarpa fruit juice in a passive avoidance test in rats. Folia Med (Plovdiv) 2014;56:199-203.
64.
Sharma A, Shetty M, Parida A, et al: Effect of ethanolic extract of Acacia auriculiformis leaves on learning and memory in rats. Pharmacognosy Res 2014;6:246-250.
65.
Salin ML, McCord JM: Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase. J Clin Investi 1975;56:1319-1323.
66.
Ansari MA, Scheff SW: Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 2010;69:155-167.
67.
Celik VK, Ersan E, Ersan S, et al: Plasma catalase, glutathione-S-transferase and total antioxidant activity levels of children with attention deficit and hyperactivity disorder. Adv Biosci Biotech 2013;4:183-187.
68.
Fernandez C, San Miguel E, Fernandez-briera A: Superoxide dismutase and catalase: tissue activities and relation with age in the long-lived species Margaritifera margaritifera. Biol Res 2009;42:57-68.
69.
Yadav P, Sarkar S, Bhatnagar D: Action of Capparis decidua against alloxan-induced oxidative stress and diabetes in rat tissues. Pharmacol Res 1997;36:221-228.
70.
Meister A: Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994;269:9397-9400.
71.
Fang YZ, Yang S, Wu G: Free radicals, antioxidants, and nutrition. Nutrition 2002;18:872-879.
72.
Deponte M: Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim Biophys Acta 2013;1830:3217-3266.
73.
Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
74.
Maritim AC, Sanders RA, Watkins JB 3rd: Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 2003;14:288-294.
75.
Galasko D, Montine TJ: Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark Med 2010;4:27-36.
76.
El-Missiry MA: Antioxidant enzyme, ed 1. Croatia, InTech, 2012.
77.
Uddin MS, Nasrullah M, Hossain MS, Rahman MM, Sarwar MS, Amran MS, et al: Evaluation of nootropic activity of Persicaria flaccida on cognitive performance, brain antioxidant markers and acetylcholinesterase activity in rats: implication for the management of Alzheimer's disease. Ame J Psy Neurosci 2016;4:26-37.
78.
McIntyre CK, Pal SN, Marriott LK, et al: Competition between memory systems: acetylcholine release in the hippocampus correlates negatively with good performance on an amygdala-dependent task. J Neurosci 2002;22:1171-1176.
79.
Uddin MS, Mamun AA, Hossain MS, Ashaduzzaman M, Noor Asif MA, Hossain MS, Uddin MJ, Sarker J, Asaduzzaman M: Neuroprotective effect of Phyllanthus acidus L. on learning and memory impairment in scopolamine-induced animal model of dementia and oxidative stress: natural wonder for regulating the development and progression of Alzheimer's disease. Adv Alzheimer Dis 2016;5:53-72.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.